|
Diabetes Care, Vol 21, Issue 1 69-75, Copyright © 1998 by American Diabetes Association
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group
H Miettinen, S Lehto, V Salomaa, M Mahonen, M Niemela, SM Haffner, K Pyorala and J Tuomilehto
Department of Medicine, University of Texas Health Science Center at San Antonio, USA. heikki.miettinen@uku.fi
OBJECTIVE: To study diabetic and nondiabetic patients with their first
myocardial infarction to determine overall 1-year mortality,
out-of-hospital mortality, 28-day mortality of hospitalized patients, and
1-year mortality of 28-day survivors. RESEARCH DESIGN AND METHODS: This
study--based on the FINMONICA Myocardial Infarction Register, a part of the
Finnish contribution to the WHO MONICA Project (World Health Organization
Multinational Monitoring of Trends and Determinants of Cardiovascular
Disease)--covered coronary heart disease (CHD) deaths and acute CHD events
occurring during hospitalization among residents of Finland aged 25-64
years in three geographically defined areas. The study population comprised
620 diabetic and 3,445 nondiabetic patients who had their first myocardial
infarction during the years 1988-1992. RESULTS: The age- and area-adjusted
mortality rates and hazard ratios (HRs) for diabetic versus nondiabetic
patients (95% CI) were as follows: The 1-year mortality rate was 44.2% in
diabetic men and 32.6% in nondiabetic men (HR, 1.38; 1.18-1.61) and 36.9%
in diabetic women and 20.2% in nondiabetic women (HR, 1.86; 1.40-2.46); the
out-of-hospital mortality rate was 28.3% in diabetic men and 22.4% in
nondiabetic men (HR, 1.25; 1.03-1.52) and 10.4% in diabetic women and 11.0%
in nondiabetic women (HR, 0.95; 0.58-1.54); the 28-day mortality rate of
hospitalized patients was 14.4% in diabetic men and 8.8% in nondiabetic men
(HR, 1.58; 1.15-2.18) and 21.7% in diabetic women and 7.8% in nondiabetic
women (HR, 2.60; 1.71-3.95); and the 1-year mortality rate of 28-day
survivors was 9.6% in diabetic men and 5.0% in nondiabetic men (HR, 1.97;
1.25-3.12) and 10.7% in diabetic women and 2.5% in nondiabetic women (HR,
4.17; 2.05-8.51). CONCLUSIONS: The high mortality rate of diabetic patients
after their first myocardial infarction and the high proportion of
out-of-hospital deaths in this group imply that vigorous primary and
secondary preventive measures should become an integral part of their
medical care.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. B. Giorda, A. Avogaro, M. Maggini, F. Lombardo, E. Mannucci, S. Turco, S. S. Alegiani, R. Raschetti, M. Velussi, E. Ferrannini, et al.
Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes: Epidemiology and risk factors
Diabetes Care,
November 1, 2008;
31(11):
2154 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. van Golde, M. S. Ruiter, N. C. Schaper, S. Voo, J. Waltenberger, W. H. Backes, M. J. Post, and M. S. Huijberts
Impaired Collateral Recruitment and Outward Remodeling in Experimental Diabetes
Diabetes,
October 1, 2008;
57(10):
2818 - 2823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Barengo, S. Katoh, V. Moltchanov, N. Tajima, and J. Tuomilehto
The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study
Eur. Heart J.,
August 1, 2008;
29(15):
1889 - 1895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Nicholls, E. M. Tuzcu, S. Kalidindi, K. Wolski, K.-W. Moon, I. Sipahi, P. Schoenhagen, and S. E. Nissen
Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
255 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. White Jr
Do People With Diabetes Need Statins?
The Diabetes Educator,
July 1, 2008;
34(4):
664 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Betteridge, R. A. DeFronzo, and R. J. Chilton
PROactive: time for a critical appraisal
Eur. Heart J.,
April 2, 2008;
29(8):
969 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Nesto
LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?
Clin. Diabetes,
January 1, 2008;
26(1):
8 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kapur and R. De Palma
Mortality after myocardial infarction in patients with diabetes mellitus
Heart,
December 1, 2007;
93(12):
1504 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Williams, M. I. Chimowitz, G. A. Cotsonis, M. J. Lynn, S. P. Waddy, and for the WASID Investigators
Gender Differences in Outcomes Among Patients With Symptomatic Intracranial Arterial Stenosis
Stroke,
July 1, 2007;
38(7):
2055 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Erdmann, J. A. Dormandy, B. Charbonnel, M. Massi-Benedetti, I. K. Moules, A. M. Skene, and on behalf of the PROactive Investigators
The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes and Previous Myocardial Infarction: Results From the PROactive (PROactive 05) Study
J. Am. Coll. Cardiol.,
May 1, 2007;
49(17):
1772 - 1780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, N. Sambandam, X. Han, R. W. Gross, M. Courtois, A. Kovacs, M. Febbraio, B. N. Finck, and D. P. Kelly
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy
Circ. Res.,
April 27, 2007;
100(8):
1208 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Madamanchi and M. S. Runge
Mitochondrial Dysfunction in Atherosclerosis
Circ. Res.,
March 2, 2007;
100(4):
460 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dotevall, A. Rosengren, M. Bartnik, K. Malmberg, J. Ohrvik, M. Simoons, L. Ryden, and on behalf of the Euro Heart Survey Investigators
Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease
Eur. Heart J.,
February 1, 2007;
28(3):
310 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Vinik and D. Ziegler
Diabetic Cardiovascular Autonomic Neuropathy
Circulation,
January 23, 2007;
115(3):
387 - 397.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Reasner
Rational therapy of mixed dyslipidaemia in a patient with diabetes
The British Journal of Diabetes & Vascular Disease,
January 1, 2007;
7(1):
25 - 30.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Elrod, J. J. M. Greer, and D. J. Lefer
Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H342 - H347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wu, R. Vikramadithyan, S. Yu, C. Pau, Y. Hu, I. J. Goldberg, and H. M. Dansky
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
J. Lipid Res.,
October 1, 2006;
47(10):
2215 - 2222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nicolucci, S. Greenfield, and S. Mattke
Selecting indicators for the quality of diabetes care at the health systems level in OECD countries
Int. J. Qual. Health Care,
September 1, 2006;
18(suppl_1):
26 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Bowden, M. Rudock, J. Ziegler, A. B. Lehtinen, J. Xu, L. E. Wagenknecht, D. Herrington, S. S. Rich, B. I. Freedman, J. J. Carr, et al.
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study.
Diabetes,
July 1, 2006;
55(7):
1985 - 1994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shepherd, P. Barter, R. Carmena, P. Deedwania, J.-C. Fruchart, S. Haffner, J. Hsia, A. Breazna, J. LaRosa, S. Grundy, et al.
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study.
Diabetes Care,
June 1, 2006;
29(6):
1220 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Costa, M. Borges, C. David, and A. Vaz Carneiro
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials
BMJ,
May 13, 2006;
332(7550):
1115 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Thomsen, A. Riis, S. Christensen, M. Norgaard, and H. T. Sorensen
Diabetes and 30-Day Mortality From Peptic Ulcer Bleeding and Perforation: A Danish population-based cohort study
Diabetes Care,
April 1, 2006;
29(4):
805 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Grundy
Diabetes and Coronary Risk Equivalency: What does it mean?
Diabetes Care,
February 1, 2006;
29(2):
457 - 460.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, F. Y. Lee, G. Barrera, H. Lee, C. Vales, F. J. Gonzalez, T. M. Willson, and P. A. Edwards
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
PNAS,
January 24, 2006;
103(4):
1006 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Solano and R. B. Goldberg
Lipid Management in Type 2 Diabetes
Clin. Diabetes,
January 1, 2006;
24(1):
27 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. M. Greer, D. P. Ware, and D. J. Lefer
Myocardial infarction and heart failure in the db/db diabetic mouse
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H146 - H153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, D. J.M. Isaman, S. Messinger, M. B. Brown, R. Klein, M. Brandle, and W. H. Herman
A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost
Diabetes Care,
December 1, 2005;
28(12):
2856 - 2863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F Van Gaal, F. Peiffer, and D. Ballaux
Reducing cardiovascular risk in patients with type 2 diabetes: the potential contribution of nicotinic acid
The British Journal of Diabetes & Vascular Disease,
November 1, 2005;
5(6):
344 - 350.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Fasy
Assessing Cardiovascular Risk in Asymptomatic Diabetes: The DIAD Study
Clin. Diabetes,
July 1, 2005;
23(3):
126 - 127.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, J. M. Tsutsui, E. L. O'Leary, F. Xie, A. C. McGrain, and T. R. Porter
Noninvasive Diagnosis of Coronary Artery Disease in Patients With Diabetes by Dobutamine Stress Real-Time Myocardial Contrast Perfusion Imaging
Diabetes Care,
July 1, 2005;
28(7):
1662 - 1667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Beishuizen, J. W. Jukema, J. T. Tamsma, M. A. van de Ree, J. C. M. van der Vijver, H. Putter, A. C. Maan, A. E. Meinders, and M. V. Huisman
No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Diabetes Care,
July 1, 2005;
28(7):
1675 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Libby, D. M. Nathan, K. Abraham, J. D. Brunzell, J. E. Fradkin, S. M. Haffner, W. Hsueh, M. Rewers, B. T. Roberts, P. J. Savage, et al.
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus
Circulation,
June 28, 2005;
111(25):
3489 - 3493.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Molnar, S. Yu, N. Mzhavia, C. Pau, I. Chereshnev, and H. M. Dansky
Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice
Circ. Res.,
June 10, 2005;
96(11):
1178 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Clough, D. J. Schneider, B. E. Sobel, M. F. White, M. P. Wadsworth, and D. J. Taatjes
Attenuation of Accumulation of Neointimal Lipid by Pioglitazone in Mice Genetically Deficient in Insulin Receptor Substrate-2 and Apolipoprotein E
J. Histochem. Cytochem.,
May 1, 2005;
53(5):
603 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cusick, A. D. Meleth, E. Agron, M. R. Fisher, G. F. Reed, G. L. Knatterud, F. B. Barton, M. D. Davis, F. L. Ferris III, E. Y. Chew, et al.
Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27
Diabetes Care,
March 1, 2005;
28(3):
617 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-L. Yue, W. Bao, J.-L. Gu, J. Cui, L. Tao, X.-L. Ma, E. H. Ohlstein, and B. M. Jucker
Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury
Diabetes,
February 1, 2005;
54(2):
554 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Di Carli and R. Hachamovitch
Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
50 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S G Wannamethee, A G Shaper, and L Lennon
Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease
Heart,
December 1, 2004;
90(12):
1398 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Fox, S. Coady, P. D. Sorlie, D. Levy, J. B. Meigs, R. B. D'Agostino Sr, P. W. F. Wilson, and P. J. Savage
Trends in Cardiovascular Complications of Diabetes
JAMA,
November 24, 2004;
292(20):
2495 - 2499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Malik, N. D. Wong, S. S. Franklin, T. V. Kamath, G. J. L'Italien, J. R. Pio, and G. R. Williams
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
Circulation,
September 7, 2004;
110(10):
1245 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Franklin, R. J. Goldberg, F. Spencer, W. Klein, A. Budaj, D. Brieger, M. Marre, P. G. Steg, N. Gowda, J. M. Gore, et al.
Implications of Diabetes in Patients With Acute Coronary Syndromes: The Global Registry of Acute Coronary Events
Arch Intern Med,
July 12, 2004;
164(13):
1457 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tschoepe and W. Burchert
Non-invasive imaging for coronary artery disease in diabetes
The British Journal of Diabetes & Vascular Disease,
July 1, 2004;
4(4):
245 - 250.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D.J. Betteridge
Treating dyslipidaemia in the patient with type 2 diabetes
Eur. Heart J. Suppl.,
July 1, 2004;
6(suppl_C):
C28 - C33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe
Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Arch Intern Med,
May 10, 2004;
164(9):
934 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Winer and J. R. Sowers
Epidemiology of Diabetes
J. Clin. Pharmacol.,
April 1, 2004;
44(4):
397 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mudaliar
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
J. Clin. Pharmacol.,
April 1, 2004;
44(4):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hanefeld, M. Cagatay, T. Petrowitsch, D. Neuser, D. Petzinna, and M. Rupp
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
Eur. Heart J.,
January 1, 2004;
25(1):
10 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Snell-Bergeon, J. E. Hokanson, L. Jensen, T. MacKenzie, G. Kinney, D. Dabelea, R. H. Eckel, J. Ehrlich, S. Garg, and M. Rewers
Progression of Coronary Artery Calcification in Type 1 Diabetes: The importance of glycemic control
Diabetes Care,
October 1, 2003;
26(10):
2923 - 2928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Luscher, M. A. Creager, J. A. Beckman, and F. Cosentino
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II
Circulation,
September 30, 2003;
108(13):
1655 - 1661.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. L Williams, B. Noronha, and A. G Zaman
Review: The management of acute myocardial infarction in patients with diabetes mellitus
The British Journal of Diabetes & Vascular Disease,
September 1, 2003;
3(5):
319 - 324.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Natarajan, Y. Liao, G. Cao, S. R. Lipsitz, and D. L. McGee
Sex Differences in Risk for Coronary Heart Disease Mortality Associated With Diabetes and Established Coronary Heart Disease
Arch Intern Med,
July 28, 2003;
163(14):
1735 - 1740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Koerbel and M. Korytkowski
Coronary Heart Disease in Women With Diabetes
Diabetes Spectr,
July 1, 2003;
16(3):
148 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
Inflammation and Insulin Resistance
Diabetes Care,
June 1, 2003;
26(6):
1922 - 1926.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Samarasinghe, M. Al-Mrayat, M. Vloemans, and N. Munro
NICE guidelines for management of lipids in type 2 diabetes mellitus: a practical interpretation
The British Journal of Diabetes & Vascular Disease,
May 1, 2003;
3(3):
222 - 225.
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman
Diabetic Autonomic Neuropathy
Diabetes Care,
May 1, 2003;
26(5):
1553 - 1579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Massing, K. A. Foley, C. A. Sueta, M. Chowdhury, D. P. Biggs, C. M. Alexander, and R. J. Simpson Jr.
Trends in Lipid Management Among Patients With Coronary Artery Disease: Has diabetes received the attention it deserves?
Diabetes Care,
April 1, 2003;
26(4):
991 - 997.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|